Paeoniflorin inhibits macrophage-mediated lung cancer metastasis

被引:28
|
作者
Wu Qi [1 ]
Chen Gang-Ling [2 ]
Li Ya-Juan [3 ]
Chen Yang [2 ]
Lin Fang-Zhen [2 ]
机构
[1] China Pharmaceut Univ, Res Dept Pharmacognosy, State Key Lab Nat Med, Nanjing 211198, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Dept Pharm Chinese Mat Med, Nanjing 211198, Jiangsu, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Murad Res Inst Modernized Chinese Med, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Paeoniflorin; Lung cancer; Metastasis; Alternatively activated macrophages; Tumor-associated macrophages; TUMOR; LYMPHANGIOGENESIS; ACTIVATION;
D O I
10.1016/S1875-5364(15)30098-4
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Alternatively activated macrophages are more frequently involved in tumor growth, angiogenesis, and immunosuppression. A previous study showed that paeoniflorin, the major active constituent of Paeonia lactiflora Pallas, can inhibit tumor growth and lung metastases of Lewis lung tumor-bearing mice. This study tried to investigate whether paeoniflorin inhibited lung cancer metastasis by inhibiting the alternative activation of macrophages (M2 macrophage). Using a viability assay, the cytotoxicity of paeoniflorin on Lewis lung cancer cells and peritoneal macrophages were investigated. In vitro scratch wound and in vivo lung metastasis experiments were used to test the ability to inhibit the migration of paeoniflorin and the function of M2 macrophages. Flow cytometry was performed to test the cell cycle of Lewis lung cancer cells, and to test the M2 macrophages in peritoneal macrophages and subcutaneous transplantable tumor. It was found that paeoniflorin showed no inhibitory effect on the growth of Lewis lung cancer cells and peritoneal macrophages of mouse in vitro. Paeoniflorin could attenuate the migration of LLC stimulated by alternatively activated macrophages (stimulated for 24 h and 48 h, paeoniflorin 1, 3, 10, 30, 100 mu mol.L-1, P < 0.01 or P < 0.05 vs control group). Paeoniflorin could decrease the cell populations at S phases (paeoniflorin 10, 30, 100 mu mol.L-1, P < 0.05 vs control group) and increase the cell populations at G0-G1 phases of Lewis lung cancer cells (paeoniflorin 100 mu mol.L-1, P < 0.05 vs control group) and reduce the numbers of M2 macrophages in peritoneal macrophages induced by]L-4 (paeoniflorin 1, 3, 10, 30, 100 mu mol.L-1, P < 0.01 vs Control group). Paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft and decrease the numbers of M2 macrophages in subcutaneous xenograft tumour in vivo (paeoniflorin 20, 40 mg.kg(-1), P < 0.01 vs control group). These results suggest that paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft partly through inhibiting the alternative activation of macrophages.
引用
收藏
页码:925 / 932
页数:8
相关论文
共 50 条
  • [1] Paeoniflorin inhibits macrophage-mediated lung cancer metastasis
    WU Qi
    CHEN Gang-Ling
    LI Ya-Juan
    CHEN Yang
    LIN Fang-Zhen
    Chinese Journal of Natural Medicines, 2015, 13 (12) : 925 - 932
  • [2] Apatinib inhibits macrophage-mediated epithelial-mesenchymal transition in lung cancer
    Liu, Shuliang
    Su, Lingfei
    Mu, Xuri
    Shi, Yubo
    Zhang, Aifeng
    Ge, Xingping
    RSC ADVANCES, 2018, 8 (38) : 21451 - 21459
  • [3] Identifying mechanisms of macrophage-mediated metastasis and treatment resistance in pancreatic cancer
    Wu, T. J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] CYCLOSPORINE INHIBITS MACROPHAGE-MEDIATED ANTIGEN PRESENTATION
    PALAY, DA
    CLUFF, CW
    WENTWORTH, PA
    ZIEGLER, HK
    JOURNAL OF IMMUNOLOGY, 1986, 136 (12): : 4348 - 4353
  • [5] CYCLOSPORINE INHIBITS MACROPHAGE-MEDIATED ANTIGEN PRESENTATION
    ZIEGLER, HK
    PALAY, D
    WENTWORTH, P
    CLUFF, C
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 726 - 726
  • [6] Targeted therapies prime lung cancer cells for macrophage-mediated destruction
    Vacarro, Kyle
    Allen, Juliet
    Maoz, Asaf
    Reeves, Sarah
    Hata, Aaron
    Weiskopf, Kipp
    CANCER RESEARCH, 2022, 82 (12)
  • [7] IS CANCER A MACROPHAGE-MEDIATED AUTOAGGRESSIVE DISEASE
    MUNZAROVA, M
    KOVARIK, J
    LANCET, 1987, 1 (8539): : 952 - 954
  • [8] Macrophage-Mediated Inflammation and Disease: A Focus on the Lung
    Findlay, Emily Gwyer
    Hussell, Tracy
    MEDIATORS OF INFLAMMATION, 2012, 2012
  • [9] Macrophage-mediated cancer drug delivery
    Wang, H. -F.
    Liu, Y.
    Yang, G.
    Zhao, C. -X.
    MATERIALS TODAY SUSTAINABILITY, 2021, 11-12
  • [10] Identifying mechanisms of macrophage-mediated metastasis and therapy resistance in PDAC
    Wu, Tony J.
    Cast, Oliver
    Memon, Danish
    Jimenez-Sanchez, Alejandro
    Machel, Anne
    Kehrloesser, Sebastian
    Gill, Michael B.
    Miller, Martin L.
    CANCER RESEARCH, 2019, 79 (24)